CTLA4 and cancer: Antibodies targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) function act as potent cancer immunotherapeutics, but the tumors did not respond to CTLA blockade in antibiotic-treated or GF mice (Vetizou et al., 2015).